2024年6月27日 · All formulations and fixed-dose combinations of dolutegravir (DTG) are U.S. Food and Drug Administration (FDA) approved for use in treatment-naive or treatment …

2024年7月19日 · Dolutegravir is an antiviral medicine that is used with other medications to treat HIV, the virus that can cause the acquired immunodeficiency syndrome (AIDS). Dolutegravir is …

2024年7月29日 · Applies to the following strengths: 10 mg; 25 mg; 50 mg; 5 mg. Rilpivirine dose is 25 mg orally once a day for patients switching to this drug plus rilpivirine. The manufacturer …

10 mg dispersible tablet ; 50 mg tablet; Dosage. The daily dose is administered once daily. Child 1 month and over and adult:

This document proposes the inclusion of dolutegravir (DTG) 10mg scored dispersible tablets for treatment of HIV-1 infection among pediatric patients (at least 4 weeks of age and weighing at …

Paediatric dolutegravir 10mg dispersible, scored tablets (pDTG) is a new generic formulation of DTG that allows antiretroviral treatment (ART) for children living with HIV (CLHIV) who are at …

Building on the 2020 World AIDS Day announcement on pediatric dolutegravir (10mg) dispersible, scored tablets (pDTG), CHAI is pleased to share a set of resources to support national …

2022年6月1日 · In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 mg scored, dispersible tablets, also known as …

Antiretroviral, Integrase Strand Transfer Inhibitor (INSTI) HIV infection, in combination with other antiretrovirals. The 10 mg dispersible tablet for oral solution is intended for children from at …

The dosing approach for DTG for children is simpler than it is for LPV/r: 10-milligram (mg), scored, dispersible pDTG tablets can be used from 4 weeks and 3 kg, and 50 mg, film-coated DTG …